Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
44 hedge funds and large institutions have $122M invested in Axcella Health Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 47 → 44 (-3)
8% less capital invested
Capital invested by funds: $133M → $122M (-$10.8M)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$564K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$239K |
| 3 |
JP Morgan Chase
New York
|
+$128K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$127K |
| 5 |
BlackRock
New York
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$327K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$159K |
| 3 |
Squarepoint
New York
|
-$127K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$91.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$86.2K |
AXLA Hedge Fund Activity: Q1 2021 in Review
44 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q1 2021, worth a combined $122M — down 8.2% from $133M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AXLA and 1 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 16 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $564K. The largest seller was Jacobs Levy Equity Management, cutting an estimated $327K.
- 44 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q1 2021, down from 47 in Q4 2020.
- Funds reported $122M of Axcella Health Inc. Common Stock stock for Q1 2021, down 8.2% quarter-over-quarter.
- 1 fund opened new Axcella Health Inc. Common Stock positions in Q1 2021 and 4 closed out, a net change of -3 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q1 2021 was Bridgeway Capital Management, an estimated $564K added.
- The largest Axcella Health Inc. Common Stock seller in Q1 2021 was Jacobs Levy Equity Management, an estimated $327K sold.
Based on aggregated 13F filings for Q1 2021.